Hydrochloric Acid

Hydrochloric Acid

SCHEMBL624934

CCCCCCCC[P+](CCCCCCCC)(CCCCCCCC)Cc1ccccc1.[Cl-]

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ BDKRB2 known ✓ P30411 7/20 0.70
▸ CSNK1E P49674 1/20 0.50
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ TP53 P04637 1/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ DNM1 Q05193 3/20 0.46
▸ HTT P42858 2/20 0.46
▸ KCNH2 Q12809 1/20 0.46
▸ EPHX2 P34913 1/20 0.43
▸ PKM P14618 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL20163267 1.00 BDKRB2 (0.70) BDKRB2CSNK1EMEN1KMT2ATP53
Hydrochloric Acid SCHEMBL28445004 1.00 BDKRB2 (0.70) BDKRB2CSNK1EMEN1KMT2ATP53
Hydrochloric Acid SCHEMBL5088466 1.00 BDKRB2 (0.70) BDKRB2CSNK1EMEN1KMT2ATP53
Hydrochloric Acid SCHEMBL9342631 0.98 BDKRB2 (0.68) BDKRB2CSNK1EMEN1KMT2ATP53
SCHEMBL29570302 0.98 BDKRB2 (0.67) BDKRB2CSNK1EMEN1KMT2ATP53
Hydrochloric Acid SCHEMBL5087534 0.98 BDKRB2 (0.72) BDKRB2CSNK1EMEN1KMT2ATP53
Bromide SCHEMBL20163257 0.96 BDKRB2 (0.70) BDKRB2CSNK1EMEN1KMT2ATP53
Bromide SCHEMBL624280 0.96 BDKRB2 (0.70) BDKRB2CSNK1EMEN1KMT2ATP53
Bromide SCHEMBL5092800 0.96 BDKRB2 (0.70) BDKRB2CSNK1EMEN1KMT2ATP53
Iodide SCHEMBL5085386 0.96 BDKRB2 (0.65) BDKRB2CSNK1EMEN1KMT2ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 318 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115850887-A Low-cost low-compression permanent deformation fluororubber composition and preparation method thereof 江苏中煜橡塑科技有限公司 2023-03-28 — — CN claimed
JP-2005524748-A — — 2005-08-18 — — JP claimed
EP-1501887-A1 COMPOSITION FOR IMPROVING ADHESION OF BASE-RESISTANT FLUOROELASTOMERS TO METAL, CERAMIC OR GLASS SUBSTRATES DUPONT DOW ELASTOMERS L.L.C. (US) 2005-02-02 — — EP claimed
US-20030225189-A1 Composition for improving adhesion of base-resistant fluoroelastomers to metal, ceramic or glass substrates DUPONT DOW ELASTOMERS LLC 2003-12-04 — — US claimed
WO-2003095535-A1 COMPOSITION FOR IMPROVING ADHESION OF BASE-RESISTANT FLUOROELASTOMERS TO METAL, CERAMIC OR GLASS SUBSTRATES DUPONT DOW ELASTOMERS L.L.C. (US) 2003-11-20 — — WO claimed
EP-0561033-B1 Polymeric phoshonium salts providing enhanced chemiluminescence from 1,2-dioxetanes, and their use. LUMIGEN INC (US) 2000-03-15 — — EP claimed
US-5658671-A ARTICLE COATED WITH COMPOSITION COMPRISING FLUOROELASTOMER, QUATERNARY AMMONIUM OR PHOSPHONIUM ACCELERATOR, POLYOL, ACID ACCEPTOR, OIL-SOLUBLE CHELATING AGENT, ORGANIC SOLVENT MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1997-08-19 — — US claimed
US-5451625-A FOR USE IN THE PREPARATION OF AUTOMOTIVE GASKETS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1995-09-19 — — US claimed
US-5393469-A Triggering dioxetane with activating agents consisting of acids, bases, salts, enzymes, inorganic or organic catalysts and electron donors; used for immunoassay and nucleic acid assay LUMIGEN, INC. (US) 1995-02-28 — — US claimed
EP-0574319-A1 Fluoroelastomer coating composition MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1993-12-15 — — EP claimed
EP-0561033-A1 Polymeric phoshonium salts providng enhanced chemiluminescence from 1,2-dioxetanes LUMIGEN, INC. (US) 1993-09-22 — — EP claimed
US-20260098005-A1 NON-FLUORINATED RESORCINOL AND HYDROQUINONE ANALOGS AS CURING AGENTS FOR FLUOROELASTOMERS THE CHEMOURS COMPANY FC, LLC (US) 2026-04-09 — — US disclosed
US-20250346791-A1 FLUORORUBBER COMPOSITION NOK CORPORATION (JP) 2025-11-13 — — US disclosed
EP-4602105-A1 CURABLE FLUOROELASTOMER COMPOSITIONS AND LOW-FRICTION CURED FLUOROELASTOMERS (FKM) FORMED THEREFROM The Chemours Company FC, LLC (US) 2025-08-20 — — EP disclosed
EP-4590761-A1 NON-FLUORINATED RESORCINOL AND HYDROQUINONE ANALOGS AS CURING AGENTS FOR FLUOROELASTOMERS The Chemours Company FC, LLC (US) 2025-07-30 — — EP disclosed
US-4830920-A WORKABILITY, MECHANICAL PROPERTIES ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1989-05-16 — — US disclosed
US-4690994-A HEXAFLUOROPROPYLENE VINYLIDENE FLUORIDE POLYMERS ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1987-09-01 — — US disclosed
EP-0186180-A2 High molecular weight fluoroelastomer Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1986-07-02 — — EP disclosed
EP-0140207-A2 A process for rapidly curing a brominated fluoroelastomer E.I. DU PONT DE NEMOURS AND COMPANY (US) 1985-05-08 — — EP disclosed
US-4160116-A FROM THE CORRESPONDING OXIDE BY HYDRATION USING ORGANIC PHOSPHONIUM HALIDE CATALYST, CARBON DIOXIDE SHOWA DENKO K.K. (JP) 1979-07-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260098005-A1 NON-FLUORINATED RESORCINOL AND HYDROQUINONE ANALOGS AS CURING AGENTS FOR FLUOROELASTOMERS CBR1, NAF1, CBR3 BDKRB2 2640/4885CSNK1E 986/4885MEN1 2683/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback